MediWound Competitors and Similar CompaniesClear all

MediWound's competitors and similar companies include Immatics.
MediWound
MediWound
MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care.
Immatics
Immatics
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
Type
Type
Public
Type
Public
Tags
Locations
Locations
Yavne, IL HQ
Rüsselsheim Am Main, DE
Wilmington, US
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
München, DE
Houston, US
Employees
Employees
111
Employees
29723% increase
Valuation ($)
Valuation ($)
196.3 m
Valuation ($)
1.1 b

Financial

Revenue (est.)
Revenue (est.)
$17m (FY, 2025)
Revenue (est.)
€48.3m (FY, 2025)
Cost of goods
Cost of goods
$13.1m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
$4.1m (FY, 2025)
Gross profit
€53m (FY, 2025)
Net income
Net income
($23.9m) (FY, 2025)
Net income
(€196.4m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase

Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.

View company